🔍 DHTs bring many potential benefits to clinical research, but there are still technical challenges to overcome for DHTs to be used in research across populations, including pediatric participants. 🏃♂️ During a recent session of Digital Health Monthly, Junrui Di joined Rakesh Pilkar to review the results of the study, Measuring Activity and Gait in Children with DHTs, and shed light on the intricacies of this project. 📔 Read the recap here: https://hubs.la/Q02F26Zm0 #DigitalHealthMonthly #DHT #PediatricResearch #ClinicalResearch
ActiGraph
Biotechnology Research
Pensacola, FL 4,865 followers
Pioneering the digital transformation of clinical research
About us
ActiGraph is pioneering the digital transformation of clinical research. We provide end-to-end digital health technology (DHT) solutions by integrating and operationalizing the best wearables, software, and algorithms to generate reliable evidence and get the right treatments to the right patients, faster. ActiGraph’s medical-grade wearable technology platform has been used to capture real-world, continuous digital measures of sleep, activity, and mobility for nearly 250 industry-sponsored clinical trials and thousands of academic research and public health studies. Appearing in over 23,000 published scientific papers to date, ActiGraph is the most experienced and trusted wearable technology partner in the industry.
- Website
-
http://www.theactigraph.com/
External link for ActiGraph
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Pensacola, FL
- Type
- Privately Held
- Founded
- 2004
Locations
-
Primary
Get directions
49 East Chase Street
Pensacola, FL 32502, US
Employees at ActiGraph
Updates
-
Couldn’t join us for this week’s Digital Health Monthly webinar? No problem! DHT 101 for Clinical Research is now available on-demand. 🎬 https://hubs.la/Q02DBNTr0 Watch now to learn more about the use of wearable-derived data as endpoints in clinical trials, addressing important points along the journey including - ☑️ The definition of DHT ☑️ Common uses in regulated trials ☑️ Key validation evidence ☑️ Operational deployment considerations #DigitalHealthMonthly #DHT #ClinicalTrials #Regulatory #Validation
Digital Health Monthly: DHT 101 | ActiGraph
theactigraph.com
-
Don't miss out! There is still time to register for and join the public meeting, co-led by FDA and Digital Medicine Society (DiMe), sharing insights to support the use of patient-generated health data in medical device development 👉 https://lnkd.in/ej93__-2 We are delighted to be part of this impressive agenda and hope you can join the conversation! 🔷 6/26, 11:30am ET, Jeremy Wyatt will participate in the keynote panel discussion, Vision: 2023: Advancing Clinical Research with Patient-Generated Health Data 🔷 6/27, 1:00pm ET, Christine Cong Guo will present in the session, From Rarity to Clarity: PGHD's Role in Rare Diseases, to share key lessons learned around digital endpoint development #patientcentricity #datacollection #clinicaltrials
🚨🚨🚨 Last call to register! Our FREE public meeting led by FDA and the Digital Medicine Society (DiMe) starts tomorrow! Join us on June 26 and June 27, from 11 a.m. to 3 p.m. ET each day. We’ll explore how patient-generated health data (PGHD) can advance remote clinical trial #data collection and facilitate high-quality clinical outcome assessment. 👥 During this 2-day public meeting, you will have the opportunity to learn about and discuss: ▪️ How to implement PGHD throughout the total product life cycle development of medical device development ▪️ Tangible case examples of how PGHD has informed medical devices and can improve return on investment ▪️ How PGHD can help improve health equity by promoting inclusivity in research studies ▪️ Case-based learning on the use of PGHD for medical device developers, scientists, and patients 🔗 Register today and join us for this unique opportunity to learn alongside industry leaders and contribute to future work on resources to advance the use of PGHD in clinical research and regulatory science. https://lnkd.in/ej93__-2 AbbVie ActiGraph Advanced Research Projects Agency for Health (ARPA-H) Bellerophon Therapeutics Clario COPD Foundation Empatica Evidation FasterCures FDA Google HITea With Grace Jackson Heart Study, Koneksa Medable, Inc The Michael J. Fox Foundation for Parkinson's Research National Organization for Rare Disorders Netherlands Organisation for Applied Scientific Research TNO The Light Collective Tidepool Verily VivoSense, Inc. Walgreens Boots Alliance White House Office of Science and Technology Policy WHOOP
Using PGHD in medical device development – Digital Medicine Society (DiMe)
https://dimesociety.org
-
🙏 Thank you to everyone who visited us at #ICAMPAM2024! It was inspiring to connect with experts in ambulatory monitoring and movement tracking. Let's continue to innovate and improve health outcomes together! Let’s reconnect: https://hubs.la/Q02D2yv30 #ICAMPAM2024 #AmbulatoryMonitoring #ActiGraph
-
-
The life sciences community faces many challenges. But after DIA 2024, it’s equally evident that collaborative efforts are yielding solutions. Over the last several days, we’ve had the opportunity to share more about the impact of our digital health technologies in clinical research and the pleasure of connecting with so many people working hard to make a difference. Together, we will continue to enhance healthcare around the world. 💙 #DIA2024 #LifeSciences #DigitalHealthTechnologies #DHT #ActiGraph
-
-
🚩 Don't miss our upcoming webinar on June 25th - DHT 101 for Clinical Research: Foundations, Regulations, and Real-World Applications! The quality and quantity of data that digital health technologies (DHTs) capture is paving the way for a more patient-centric and information rich drug development process. Please join us as Christine Cong Guo reviews DHT definitions, regulatory terminology, and use cases to help you capture the value these tools bring to clinical development. ☑️ Register here: https://hubs.la/Q02CF2Sx0 #DigitalHealthMonthly #DHT #ClinicalTrials #ClinicalResearch #Regulatory
-
-
ActiGraph is thrilled to be at ICAMPAM 2024! Stop by our stand to discover how we're contributing to the field of ambulatory monitoring of physical activity and movement. Let's exchange ideas and insights! 🤝 #ICAMPAM2024 #AmbulatoryMonitoring #ActiGraph
-
-
🔜⏲️ The countdown is on…Get ready for PanAgora Pharma 7th Annual Digital Biomarkers in Clinical Trials at Roche headquarters in Basel on June 26! Stop by our stand and meet the ActiGraph team - @Jodie Lyons, Jonathan Lake, John Bailey - and please join us for Jeremy Wyatt's presentation to learn more about The Digital Endpoint Collaboration to accelerate Outcome DEvelopment, (DECODE)! We’d love to discuss how we can work together to accelerate adoption of digital health technology for more effective and patient-centric clinical trials! #DigitalBiomarkers #DigitalEndpoints #DHT #DrugDevelopment #ClinicalTrials #PatientCentricity #ActiGraph
-
-
Introducing two new features to support flexibility and usability in studies using ActiGraph LEAP devices - ✅ Duty Cycles ✅ Event-Based Data Capture Read more details here: https://hubs.la/Q02CgKG80 👉 These new features will improve usability at the study team, site, and participant level, increasing flexibility and further developing ActiGraph LEAP as a fit-for-purpose, wearable DHT to help uncover the unique clinical insights that are possible with multisensor data. Kim Rejndrup #Usability #DHT #FitforPurpose #DataCapture
Flexible Features in Fit-For-Purpose Wearable Digital Health Technology
blog.theactigraph.com
-
DIA 2024 is underway in San Diego, and we want to see you! ⛱ Visit booth #2216 to meet Richard Kimble, Michael Philcock, and Samantha Gandy, and Jeremy Wyatt to explore innovative solutions, and be part of the conversation! Let's reimagine processes together! ✅ Don’t forget to submit your vote for the ActiGraph LEAP in the DIA Best in Show Awards! #DIA2024 #LifeSciences #ActiGraph
-